Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

366 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A metabolic dependency of EBV can be targeted to hinder B cell transformation.
Müller-Durovic B, Jäger J, Engelmann C, Schuhmachers P, Altermatt S, Schlup Y, Duthaler U, Makowiec C, Unterstab G, Roffeis S, Xhafa E, Assmann N, Trulsson F, Steiner R, Edwards-Hicks J, West J, Turner L, Develioglu L, Ivanek R, Azzi T, Dehio P, Berger C; Swiss Transplant Cohort Study; Kuzmin D, Saboz S, Mautner J, Löliger J, Geigges M, Palianina D, Khanna N, Dirnhofer S, Münz C, Bantug GR, Hess C. Müller-Durovic B, et al. Among authors: dirnhofer s. Science. 2024 Jul 5;385(6704):eadk4898. doi: 10.1126/science.adk4898. Epub 2024 Jul 5. Science. 2024. PMID: 38781354
Tonsil explants as a human in vitro model to study vaccine responses.
Bonaiti E, Muraro MG, Robert PA, Jakscha J, Dirnhofer S, Martin I, Berger CT. Bonaiti E, et al. Among authors: dirnhofer s. Front Immunol. 2024 Sep 17;15:1425455. doi: 10.3389/fimmu.2024.1425455. eCollection 2024. Front Immunol. 2024. PMID: 39355250 Free PMC article.
Development of Resistance to Type II JAK2 Inhibitors in MPN Depends on AXL Kinase and Is Targetable.
Codilupi T, Szybinski J, Arunasalam S, Jungius S, Dunbar AC, Stivala S, Brkic S, Albrecht C, Vokalova L, Yang JL, Buczak K, Ghosh N, Passweg JR, Rovo A, Angelillo-Scherrer A, Pankov D, Dirnhofer S, Levine RL, Koche R, Meyer SC. Codilupi T, et al. Among authors: dirnhofer s. Clin Cancer Res. 2024 Feb 1;30(3):586-599. doi: 10.1158/1078-0432.CCR-23-0163. Clin Cancer Res. 2024. PMID: 37992313 Free PMC article.
Distinct subtypes of post-transplant lymphoproliferative disorders: CHIP-like mutations in early lesions and substantial mutational differences between EBV-positive and EBV-negative diffuse large B-cell lymphomas.
Ivanova VS, Menter T, Cui N, Leary P, Zinner C, Halter JP, Stenner F, Dirnhofer S, Müller A, Tzankov A. Ivanova VS, et al. Among authors: dirnhofer s. Br J Haematol. 2025 Jan 7. doi: 10.1111/bjh.19952. Online ahead of print. Br J Haematol. 2025. PMID: 39777628
Integrating genetic subtypes with PET scan monitoring to predict outcome in diffuse large B-cell lymphoma.
Mendeville MS, Janssen J, Los-de Vries GT, van Dijk E, Richter J, Nijland M, Roemer MGM, Stathi P, Hijmering NJ, Bladergroen R, Pelaz DA, Diepstra A, Eertink CJ, Burggraaff CN, Kim Y, Lugtenburg PJ, van den Berg A, Tzankov A, Dirnhofer S, Dührsen U, Hüttmann A, Klapper W, Zijlstra JM, Ylstra B, de Jong D. Mendeville MS, et al. Among authors: dirnhofer s. Nat Commun. 2025 Jan 2;16(1):109. doi: 10.1038/s41467-024-55614-y. Nat Commun. 2025. PMID: 39747123 Free PMC article.
Lymphoma Classifications, How to Develop a Future Unified Taxonomy.
Campo E, Dierickx D, Dirnhofer S, Dunleavy K, Gaulard P, Hasserjian RP, Jaffe ES, Kim WS, King RL, Lim MS, Ott G, Piris MA, Salles G, Siebert R. Campo E, et al. Among authors: dirnhofer s. J Clin Oncol. 2024 Sep 20;42(27):3177-3182. doi: 10.1200/JCO.24.00070. Epub 2024 Jul 17. J Clin Oncol. 2024. PMID: 39018505 No abstract available.
366 results